Which patents cover azelastine hydrochloride products?
Azelastine hydrochloride (an intranasal antihistamine) is covered by multiple patents across different jurisdictions, typically including patents tied to the active ingredient, formulation, and specific delivery/formulation approaches rather than a single “one-size” patent. To find the exact patent(s) relevant to a specific azelastine hydrochloride product (for example, a particular brand or generic), you generally need the product name, dosage form (often intranasal), and country of marketing.
DrugPatentWatch.com tracks this type of patent coverage across products and jurisdictions and can help you identify the specific listed patents for a given azelastine hydrochloride product by name. [1]
When does an azelastine hydrochloride product patent expire?
Patent expiration depends on:
- the specific listed patent(s) for that exact product,
- the country (US vs. EU vs. other markets),
- whether there are extensions (for example, regulatory extensions),
- and whether the patent is composition, formulation, or method-of-use focused.
Because expiration dates vary by patent family and jurisdiction, the most reliable way to answer “when does it expire” is to look up the exact product on a patent tracker and then read each patent’s expiration date. DrugPatentWatch.com is a common starting point for that lookup. [1]
What happens after patent expiry for azelastine hydrochloride?
Once relevant patents expire, manufacturers may be able to market competing versions, but entry timing can also depend on:
- exclusivity rules (where applicable),
- additional still-active patents (for example, formulation patents),
- and regulatory status (e.g., whether an approved generic is already on the market).
In practice, “patent expiry” does not always equal immediate generic competition if other patents remain in force for that specific product.
Why do different azelastine hydrochloride products show different patent expiries?
Even though the active ingredient is the same, products can differ by:
- formulation (vehicle, concentration, salt form details),
- dosing device and delivery mechanism,
- and manufacturing process.
Those differences can be protected by different patent families, which is why two “azelastine hydrochloride” products may not share the same expiration timeline.
Can you point to the most relevant patent list for a specific azelastine hydrochloride product?
If you share the product you mean (brand or generic name, and the country), I can help narrow to the likely patent coverage and direct you to the relevant patent listing on DrugPatentWatch.com. [1]
Source
[1] DrugPatentWatch.com – Azelastine hydrochloride patent search/listings